Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 16 Feb 2023
Abbott has previously opposed legislation to test strips, but noted an 89% increase in fentanyl deaths in Texas over the past year.
Read Full NewsFDA approves a label update for the BEAR implant, which was previously approved in 2020.
Physicians experience significant challenges with increasing administrative burdens impacting patient care. Study shows AI scribes can help reduce burnout.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending January 23, 2026.
Jerel Banks, MD, PhD, chief executive officer of Benitec Biopharma, reviews early phase 1b/2a clinical signals, mechanism, and next steps for BB-301 in oculopharyngeal muscular dystrophy.
Benitec Biopharma reveals promising results for BB-301, a gene therapy showing significant improvements in swallowing function for OPMD patients.
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is on the ALS Treatment pathways!
GLP-1 Discontinuation Results in Significant Weight Regain, With Michael Weintraub, MD
1.
The way that miR-377 inhibits cells that cause prostate cancer.
2.
The importance of breast cancer screening
3.
Stem Cell Selection Unneeded for SSc Transplant Therapy?
4.
Non-small cell lung cancer patients who are ineligible for platinum-based chemotherapy benefit from atezolizumab monotherapy.
5.
Radiotherapy after mastectomy can be avoided, study finds
1.
The Miracle of Thyrogen Injection: A New Hope for Thyroid Cancer Treatment
2.
Unlocking The Causes And Risk Factors Of Breast Cancer
3.
Transfusing the Future: Exploring the Possibilities of Blood Transfusions
4.
Seeing Beyond the Pink Ribbon: AI's New Battle Against Breast Cancer
5.
Multiple Primary Lung Cancer: Multidisciplinary Advances in Diagnosis and Care
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary
2.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part II
3.
Efficient Management of First line ALK-rearranged NSCLC - Part III
4.
Navigating the Complexities of Ph Negative ALL - Part XV
5.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge